Biogenic silver nanoparticles' effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and

Silver nanoparticles (AgNPs) are widely incorporated into different hygiene, personal care, and healthcare products. However, few studies have been undertaken to determine the effects of biogenic AgNPs on human health. The effect of biosynthesized AgNPs using the fungus Aspergillus tubingensis cultu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology research (Cambridge) 2019-12, Vol.8 (6), p.789-81
Hauptverfasser: Ottoni, Cristiane Angélica, Maria, Durvanei Augusto, Gonçalves, Priscila Jane Romano de Oliveira, de Araújo, Welington Luiz, de Souza, Ana Olívia
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 81
container_issue 6
container_start_page 789
container_title Toxicology research (Cambridge)
container_volume 8
creator Ottoni, Cristiane Angélica
Maria, Durvanei Augusto
Gonçalves, Priscila Jane Romano de Oliveira
de Araújo, Welington Luiz
de Souza, Ana Olívia
description Silver nanoparticles (AgNPs) are widely incorporated into different hygiene, personal care, and healthcare products. However, few studies have been undertaken to determine the effects of biogenic AgNPs on human health. The effect of biosynthesized AgNPs using the fungus Aspergillus tubingensis culture was evaluated on human umbilical vein endothelial cells (HUVECs), normal human fibroblasts (FN1), human hepatoma cells (HEPG2) and a Galleria mellonella model. HUVECs were more susceptible to biogenic AgNPs than normal fibroblasts FN1 and intense cytotoxicity was observed only for very high concentrations at and above 2.5 μM for both cells. Normal human fibroblasts FN1 exposed to AgNPs for 24 h showed viability of 98.83 ± 8.40% and 94.86 ± 5.50% for 1.25 and 2.5 μM, respectively. At 5 and 10 μM, related to the control, an increase in cell viability was observed being 112.66 ± 9.94% and 117.86 ± 8.86%, respectively. Similar results were obtained for treatment for 48 and 72 h. At 1.25, 2.5, 5 and 10 μM of AgNPs, at 24 h, HUVECs showed 51.34 ± 7.47%, 27.01 ± 5.77%, 26.00 ± 3.03% and 27.64 ± 5.85% of viability, respectively. No alteration in cell distribution among different cycle phases was observed after HUVEC and normal fibroblast FN1 exposure to AgNPs from 0.01 to 1 μM for 24, 48 and 72 h. Based on the clonogenic assay, nanoparticles successfully inhibited HEPG2 cell proliferation when exposed to concentrations up to 1 μM. In addition to that, AgNPs did not induce senescence and no morphological alteration was observed by scanning electron microscopy on the endothelial cells. In the larvae of the wax moth, Galleria mellonella , a model for toxicity, AgNPs showed no significant effects, which corroborates to the safety of their use in mammalian cells. These results demonstrate that the use of A. tubingensis AgNPs is a promising biotechnological approach and these AgNPs can be applied in several biomedical situations. Biogenic silver nanoparticles are ecofriendly and offers valuable possibilities of applications in several industrial areas.
doi_str_mv 10.1039/c9tx00091g
format Article
fullrecord <record><control><sourceid>rsc</sourceid><recordid>TN_cdi_rsc_primary_c9tx00091g</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c9tx00091g</sourcerecordid><originalsourceid>FETCH-rsc_primary_c9tx00091g3</originalsourceid><addsrcrecordid>eNqFTz1PwzAQtRBIVG2X7pWOiaUtTtwAWUH9GBkY2CLHObeHnHNkuxH8eyKBYCvT-9STnhCzTK4yqco7U6YPKWWZHS7EKJfrYrku1OPlL8_frsU0xvehIx9kfq-KkeifyB-QyUAk12MA1uw7HRIZh_EW0Fo0KYJnOJ5azXBqa3JktIMeiQG58emIjgbDoHNxAexDO6jvuqU6-NrpmIZkv3nZ5QvQ3EzEldUu4vQHx2K-3bw-75chmqoL1OrwWf39UWNxcy6vusaq_za-AFvAWuU</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Biogenic silver nanoparticles' effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Royal Society Of Chemistry Journals 2008-</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ottoni, Cristiane Angélica ; Maria, Durvanei Augusto ; Gonçalves, Priscila Jane Romano de Oliveira ; de Araújo, Welington Luiz ; de Souza, Ana Olívia</creator><creatorcontrib>Ottoni, Cristiane Angélica ; Maria, Durvanei Augusto ; Gonçalves, Priscila Jane Romano de Oliveira ; de Araújo, Welington Luiz ; de Souza, Ana Olívia</creatorcontrib><description>Silver nanoparticles (AgNPs) are widely incorporated into different hygiene, personal care, and healthcare products. However, few studies have been undertaken to determine the effects of biogenic AgNPs on human health. The effect of biosynthesized AgNPs using the fungus Aspergillus tubingensis culture was evaluated on human umbilical vein endothelial cells (HUVECs), normal human fibroblasts (FN1), human hepatoma cells (HEPG2) and a Galleria mellonella model. HUVECs were more susceptible to biogenic AgNPs than normal fibroblasts FN1 and intense cytotoxicity was observed only for very high concentrations at and above 2.5 μM for both cells. Normal human fibroblasts FN1 exposed to AgNPs for 24 h showed viability of 98.83 ± 8.40% and 94.86 ± 5.50% for 1.25 and 2.5 μM, respectively. At 5 and 10 μM, related to the control, an increase in cell viability was observed being 112.66 ± 9.94% and 117.86 ± 8.86%, respectively. Similar results were obtained for treatment for 48 and 72 h. At 1.25, 2.5, 5 and 10 μM of AgNPs, at 24 h, HUVECs showed 51.34 ± 7.47%, 27.01 ± 5.77%, 26.00 ± 3.03% and 27.64 ± 5.85% of viability, respectively. No alteration in cell distribution among different cycle phases was observed after HUVEC and normal fibroblast FN1 exposure to AgNPs from 0.01 to 1 μM for 24, 48 and 72 h. Based on the clonogenic assay, nanoparticles successfully inhibited HEPG2 cell proliferation when exposed to concentrations up to 1 μM. In addition to that, AgNPs did not induce senescence and no morphological alteration was observed by scanning electron microscopy on the endothelial cells. In the larvae of the wax moth, Galleria mellonella , a model for toxicity, AgNPs showed no significant effects, which corroborates to the safety of their use in mammalian cells. These results demonstrate that the use of A. tubingensis AgNPs is a promising biotechnological approach and these AgNPs can be applied in several biomedical situations. Biogenic silver nanoparticles are ecofriendly and offers valuable possibilities of applications in several industrial areas.</description><identifier>ISSN: 2045-452X</identifier><identifier>EISSN: 2045-4538</identifier><identifier>DOI: 10.1039/c9tx00091g</identifier><language>eng</language><ispartof>Toxicology research (Cambridge), 2019-12, Vol.8 (6), p.789-81</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Ottoni, Cristiane Angélica</creatorcontrib><creatorcontrib>Maria, Durvanei Augusto</creatorcontrib><creatorcontrib>Gonçalves, Priscila Jane Romano de Oliveira</creatorcontrib><creatorcontrib>de Araújo, Welington Luiz</creatorcontrib><creatorcontrib>de Souza, Ana Olívia</creatorcontrib><title>Biogenic silver nanoparticles' effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and</title><title>Toxicology research (Cambridge)</title><description>Silver nanoparticles (AgNPs) are widely incorporated into different hygiene, personal care, and healthcare products. However, few studies have been undertaken to determine the effects of biogenic AgNPs on human health. The effect of biosynthesized AgNPs using the fungus Aspergillus tubingensis culture was evaluated on human umbilical vein endothelial cells (HUVECs), normal human fibroblasts (FN1), human hepatoma cells (HEPG2) and a Galleria mellonella model. HUVECs were more susceptible to biogenic AgNPs than normal fibroblasts FN1 and intense cytotoxicity was observed only for very high concentrations at and above 2.5 μM for both cells. Normal human fibroblasts FN1 exposed to AgNPs for 24 h showed viability of 98.83 ± 8.40% and 94.86 ± 5.50% for 1.25 and 2.5 μM, respectively. At 5 and 10 μM, related to the control, an increase in cell viability was observed being 112.66 ± 9.94% and 117.86 ± 8.86%, respectively. Similar results were obtained for treatment for 48 and 72 h. At 1.25, 2.5, 5 and 10 μM of AgNPs, at 24 h, HUVECs showed 51.34 ± 7.47%, 27.01 ± 5.77%, 26.00 ± 3.03% and 27.64 ± 5.85% of viability, respectively. No alteration in cell distribution among different cycle phases was observed after HUVEC and normal fibroblast FN1 exposure to AgNPs from 0.01 to 1 μM for 24, 48 and 72 h. Based on the clonogenic assay, nanoparticles successfully inhibited HEPG2 cell proliferation when exposed to concentrations up to 1 μM. In addition to that, AgNPs did not induce senescence and no morphological alteration was observed by scanning electron microscopy on the endothelial cells. In the larvae of the wax moth, Galleria mellonella , a model for toxicity, AgNPs showed no significant effects, which corroborates to the safety of their use in mammalian cells. These results demonstrate that the use of A. tubingensis AgNPs is a promising biotechnological approach and these AgNPs can be applied in several biomedical situations. Biogenic silver nanoparticles are ecofriendly and offers valuable possibilities of applications in several industrial areas.</description><issn>2045-452X</issn><issn>2045-4538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFTz1PwzAQtRBIVG2X7pWOiaUtTtwAWUH9GBkY2CLHObeHnHNkuxH8eyKBYCvT-9STnhCzTK4yqco7U6YPKWWZHS7EKJfrYrku1OPlL8_frsU0xvehIx9kfq-KkeifyB-QyUAk12MA1uw7HRIZh_EW0Fo0KYJnOJ5azXBqa3JktIMeiQG58emIjgbDoHNxAexDO6jvuqU6-NrpmIZkv3nZ5QvQ3EzEldUu4vQHx2K-3bw-75chmqoL1OrwWf39UWNxcy6vusaq_za-AFvAWuU</recordid><startdate>20191209</startdate><enddate>20191209</enddate><creator>Ottoni, Cristiane Angélica</creator><creator>Maria, Durvanei Augusto</creator><creator>Gonçalves, Priscila Jane Romano de Oliveira</creator><creator>de Araújo, Welington Luiz</creator><creator>de Souza, Ana Olívia</creator><scope/></search><sort><creationdate>20191209</creationdate><title>Biogenic silver nanoparticles' effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and</title><author>Ottoni, Cristiane Angélica ; Maria, Durvanei Augusto ; Gonçalves, Priscila Jane Romano de Oliveira ; de Araújo, Welington Luiz ; de Souza, Ana Olívia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rsc_primary_c9tx00091g3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ottoni, Cristiane Angélica</creatorcontrib><creatorcontrib>Maria, Durvanei Augusto</creatorcontrib><creatorcontrib>Gonçalves, Priscila Jane Romano de Oliveira</creatorcontrib><creatorcontrib>de Araújo, Welington Luiz</creatorcontrib><creatorcontrib>de Souza, Ana Olívia</creatorcontrib><jtitle>Toxicology research (Cambridge)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ottoni, Cristiane Angélica</au><au>Maria, Durvanei Augusto</au><au>Gonçalves, Priscila Jane Romano de Oliveira</au><au>de Araújo, Welington Luiz</au><au>de Souza, Ana Olívia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biogenic silver nanoparticles' effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and</atitle><jtitle>Toxicology research (Cambridge)</jtitle><date>2019-12-09</date><risdate>2019</risdate><volume>8</volume><issue>6</issue><spage>789</spage><epage>81</epage><pages>789-81</pages><issn>2045-452X</issn><eissn>2045-4538</eissn><abstract>Silver nanoparticles (AgNPs) are widely incorporated into different hygiene, personal care, and healthcare products. However, few studies have been undertaken to determine the effects of biogenic AgNPs on human health. The effect of biosynthesized AgNPs using the fungus Aspergillus tubingensis culture was evaluated on human umbilical vein endothelial cells (HUVECs), normal human fibroblasts (FN1), human hepatoma cells (HEPG2) and a Galleria mellonella model. HUVECs were more susceptible to biogenic AgNPs than normal fibroblasts FN1 and intense cytotoxicity was observed only for very high concentrations at and above 2.5 μM for both cells. Normal human fibroblasts FN1 exposed to AgNPs for 24 h showed viability of 98.83 ± 8.40% and 94.86 ± 5.50% for 1.25 and 2.5 μM, respectively. At 5 and 10 μM, related to the control, an increase in cell viability was observed being 112.66 ± 9.94% and 117.86 ± 8.86%, respectively. Similar results were obtained for treatment for 48 and 72 h. At 1.25, 2.5, 5 and 10 μM of AgNPs, at 24 h, HUVECs showed 51.34 ± 7.47%, 27.01 ± 5.77%, 26.00 ± 3.03% and 27.64 ± 5.85% of viability, respectively. No alteration in cell distribution among different cycle phases was observed after HUVEC and normal fibroblast FN1 exposure to AgNPs from 0.01 to 1 μM for 24, 48 and 72 h. Based on the clonogenic assay, nanoparticles successfully inhibited HEPG2 cell proliferation when exposed to concentrations up to 1 μM. In addition to that, AgNPs did not induce senescence and no morphological alteration was observed by scanning electron microscopy on the endothelial cells. In the larvae of the wax moth, Galleria mellonella , a model for toxicity, AgNPs showed no significant effects, which corroborates to the safety of their use in mammalian cells. These results demonstrate that the use of A. tubingensis AgNPs is a promising biotechnological approach and these AgNPs can be applied in several biomedical situations. Biogenic silver nanoparticles are ecofriendly and offers valuable possibilities of applications in several industrial areas.</abstract><doi>10.1039/c9tx00091g</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2045-452X
ispartof Toxicology research (Cambridge), 2019-12, Vol.8 (6), p.789-81
issn 2045-452X
2045-4538
language eng
recordid cdi_rsc_primary_c9tx00091g
source Oxford University Press Journals All Titles (1996-Current); Royal Society Of Chemistry Journals 2008-; PubMed Central; Alma/SFX Local Collection
title Biogenic silver nanoparticles' effects on human umbilical vein endothelial cells, normal human fibroblasts, HEPG2, and
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A56%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rsc&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biogenic%20silver%20nanoparticles'%20effects%20on%20human%20umbilical%20vein%20endothelial%20cells,%20normal%20human%20fibroblasts,%20HEPG2,%20and&rft.jtitle=Toxicology%20research%20(Cambridge)&rft.au=Ottoni,%20Cristiane%20Ang%C3%A9lica&rft.date=2019-12-09&rft.volume=8&rft.issue=6&rft.spage=789&rft.epage=81&rft.pages=789-81&rft.issn=2045-452X&rft.eissn=2045-4538&rft_id=info:doi/10.1039/c9tx00091g&rft_dat=%3Crsc%3Ec9tx00091g%3C/rsc%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true